AgInTe2 Quantum Dots for Biocompatible Near-Infrared Fluorescence
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of effective research and practical use of silver indium chalcogenide quantum dots, particularly those exhibiting high-luminance and biocompatible near-infrared fluorescence, and there is a need for a simple method to synthesize such quantum dots.
Innovation Solution
A method for synthesizing silver indium chalcogenide quantum dots (AgInE2) with a near-infrared fluorescence wavelength of 700 to 1500 nm, a fluorescence full width at half maximum of 150 nm or less, and a fluorescence quantum yield of 20% or more, using a direct synthesis process with easy-to-use reactants in a high-boiling point solvent, and covering the quantum dot surface with ligands.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional quantum dot materials are used, then fluorescence quantum yield can be achieved, but biocompatibility and near-infrared emission are limited
Solution Approach 1:
The patent uses composite material AgInE2 (where E is tellurium, selenium, or sulfur) that combines silver, indium, and chalcogen elements to achieve both biocompatibility and near-infrared emission. This composite structure allows the quantum dots to exhibit fluorescence in the 700-1500 nm range while maintaining low toxicity, resolving the contradiction between biocompatibility and near-infrared emission capability
2Manufacturing precision
If complex synthesis methods are used, then quantum dot performance can be improved, but manufacturing simplicity is reduced
Solution Approach 1:
The synthesis process is segmented into distinct stages: (1) preparing precursor solutions of silver, indium, and chalcogen compounds; (2) injecting precursors into hot oleic acid under nitrogen atmosphere; ( (3) controlling temperature profiles to achieve desired particle sizes; (4) purifying and characterizing the quantum dots. This segmentation allows precise control of each parameter to achieve high fluorescence quantum yield while maintaining overall process simplicity and reproducibility
Solution Approach 2:
The patent employs parameter changes including temperature control (heating to specific temperatures and maintaining for controlled periods), solvent selection (oleic acid as high-boiling point solvent), and precursor ratios to optimize quantum dot formation. By systematically adjusting these parameters, the method achieves high manufacturing precision for fluorescence quantum yield while keeping the synthesis approach straightforward and scalable
3Measurement precision
If quantum dots with narrow FWHM are produced, then fluorescence resolution is improved, but manufacturing complexity increases
Solution Approach 1:
The synthesis method uses dynamic temperature control and timed injection of precursors into the hot solvent to achieve uniform quantum dot formation. By dynamically adjusting reaction conditions during synthesis, the process produces quantum dots with narrow FWHM (high fluorescence resolution) while maintaining a relatively simple overall procedure that avoids complex multi-step processes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method allows for the stable mass-production of high-luminance near-infrared fluorescence quantum dots without intermediates, achieving a narrow fluorescence full width and high quantum yield, suitable for applications in optical communication and biomedical imaging.
Implementation Method 1
a fluorescence wavelength is within a range of a near-infrared region of 700 to 1500 nm
Data Source
AI summary
A quantum dot being a nanocrystal represented by AgInTe2 contains silver, indium, and tellurium, the quantum dot being a near-infrared absorbing particle